Abstract:The design of bioresponsive controlled drug delivery systems is a promising approach in cancer therapy, but it still is a major challenge capable of optimum therapeutic efficacy, i.e. no premature drug leakage in blood circulation while having a rapid and complete release in tumor tissues. In this work, a kind of PEGylated core/shell structured composite nanoparticle was developed via precipitation polymerization, where a disulfide-cross-linked poly(N-vinylcaprolactam-co-methacrylic acid) (P(VCL-s-s-MAA)) polymer shell was created to act as sheddable thermo/pH-sensitive gatekeepers, and a carboxylic acid modified mesoporous silica nanoparticles (MSN-COOH) core was applicable as an accessible reservoir to encapsulate high drug doses. At physiological conditions, the P(VCL-s-sMAA)-PEG shell underwent a distinct transition from a swollen state in pH 74 to a collapsed state in pH 5.0. Though sufficiently stable in water, composite nanoparticles were prone to fast dissociation and rupture when subjecting to 10 mM glutathione (GSH), due to the shedding of polymer walls through reductive cleavage of intermediate disulfide bonds, so that the polymer shell was active in moderating the diffusion of embedded drugs in-and-out of MSN channels. The cumulative in vitro release of DOX-loaded composite nanoparticles allowed a low trace of DOX diffusion below volume phase transition temperature (VPTT) and a significant release rate above its VPTT, while the most rapid and perfect release was achieved under a reductive environment (pH 6.5 and 10 mM GSH), mimicking that of intracellular cytosol compartments. The in vitro cell assay of blank carriers to normal cells indicated that the composite nanoparticles were suitable as drug carriers, but DOX-loaded carriers had a similar intensive toxicity to cancer cells compared with free DOX. Therefore, these stimuli responsive composite nanoparticles with a reductively sheddable and thermo/pH-responsive polymer shell gate could, in principle, be applied for in vivo cancer therapy, and synergistic drug delivery can be accomplished "just in time in a precise event over the location.

Ligand exchange triggered controlled-release targeted drug delivery system based on core-shell superparamagnetic mesoporous microspheres capped with nanoparticles

Stimuli-responsive Functionalized Mesoporous Silica Nanoparticles for Drug Release in Response to Various Biological Stimuli

Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles

A Self-Targeting and Controllable Drug Delivery System Constituting Mesoporous Silica Nanoparticles Fabricated with a Multi-Stimuli Responsive Chitosan-Based Thin Film Layer

Enzyme-Induced and Tumor-Targeted Drug Delivery System Based on Multifunctional Mesoporous Silica Nanoparticles

Fe3O4@mSiO2 Core-Shell Nanocomposite Capped with Disulfide Gatekeepers for Enzyme-Sensitive Controlled Release of Anti-Cancer Drugs.

Redox- and Temperature-Controlled Drug Release from Hollow Mesoporous Silica Nanoparticles.

A Surface-Grafted Ligand Functionalization Strategy for Coordinate Binding of Doxorubicin at Surface of PEGylated Mesoporous Silica Nanoparticles: Toward Ph-Responsive Drug Delivery

Surface functionalization of magnetic mesoporous silica nanoparticles for controlled drug release

Multifunctional Mesoporous Silica Nanoparticles for Cancer-Targeted and Controlled Drug Delivery

Bioresponsive Controlled Drug Release Based on Mesoporous Silica Nanoparticles Coated with Reductively Sheddable Polymer Shell

A multi-controlled drug delivery system based on magnetic mesoporous Fe 3 O 4 nanopaticles and a phase change material for cancer thermo-chemotherapy.

Zinc oxide end-capped Fe 3 O 4 @mSiO 2 core-shell nanocarriers as targeted and responsive drug delivery system for chemo-/ions synergistic therapeutics.

Magnetic Mesoporous Silica Microspheres with Thermo-Sensitive Polymer Shell for Controlled Drug Release

In Situ Monitoring of Intracellular Controlled Drug Release from Mesoporous Silica Nanoparticles Coated with Ph-Responsive Charge-Reversal Polymer

Ph-Responsive Magnetic Core-Shell Nanocomposites for Drug Delivery.

A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a “tumor-triggered targeting” property

Biocompatible Magnetic and Molecular Dual-Targeting Polyelectrolyte Hybrid Hollow Microspheres for Controlled Drug Release

Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo.

A theranostic nanocomposite system based on radial mesoporous silica hybridized with Fe3O4 nanoparticles for targeted magnetic field responsive chemotherapy of breast cancer

Smart “On-Off” Responsive Drug Delivery Nanosystems for Potential Imaging Diagnosis and Targeted Tumor Therapy